An upcoming US Supreme Court ruling on the legality of the sweeping tariffs that President Donald Trump rolled out in April — ...

The U.S. stock market is having a terrific year. The benchmark S&P 500 ( ^GSPC +0.67%) is up 16% in 2025 despite economic ...

On April 2, the president unveiled his touted tariff and trade policy. It featured a sweeping 10% global tariff, along with ...

CROX remains a deep value Buy, but near-term performance is challenged by tariff headwinds and weak HEYDUDE brand results.

Discover which stocks could benefit from Supreme Court tariff relief. Explore Wells Fargo’s top picks and performance ...

Wall Street analysts expect another strong year in stocks in 2026, propelled by continued AI sector gains and additional Fed ...

An upstart beverage company's stock has outperformed most of its competitors over the last two years. All it took was a ...

Children’s Place attributed the results to challenges in its e-commerce business and marketing inefficiencies, as well as the ...

Tariffs haven’t tanked the economy. In fact, GDP in the second quarter reached its strongest quarterly growth in nearly two ...

Rivian stock had been trending upward recently despite facing challenges. Here is a look at where the stock could be in a ...

Medline stock debuts at $29 after a $6.26B IPO as investors weigh debt reduction, tariffs and margin sustainability.

GreensKeeper Asset Management, an investment management company, released its third-quarter 2025 investor letter. A copy of ...